Modified Akuamma Alkaloids with Increased Potency at the Mu-opioid Receptor

Area of Science:

• Natural Product Chemistry
• Medicinal Chemistry
• Neuropharmacology

Background:

• Akuammine and pseudoakuammigine are indole alkaloids from Picralima nitida.
• These compounds are weak agonists of the mu opioid receptor (μOR) with limited antinociceptive effects.
• Understanding their interaction with opioid receptors is crucial for developing new analgesics.

Purpose of the Study:

• To synthesize and evaluate semisynthetic derivatives of akuammine and pseudoakuammigine.
• To investigate structure-activity relationships at the mu opioid receptor (μOR) and kappa opioid receptor (κOR).
• To identify derivatives with improved potency and selectivity for pain management.

Main Methods:

• Preparation of 22 semisynthetic derivatives of akuammine and pseudoakuammigine.
• In vitro evaluation of derivatives at the μOR and κOR.
• Assessment of antinociceptive efficacy using tail-flick and hot-plate assays in animal models.

Main Results:

• Identified structure-activity relationship trends for opioid receptor interactions.
• Discovered a derivative with a 70-fold increase in μOR potency and 7-fold increase in μOR selectivity.
• Demonstrated enhanced antinociceptive efficacy in vivo for the most potent derivative.

Conclusions:

• Natural product scaffolds like akuammine can be modified to develop potent opioid receptor ligands.
• Semisynthetic derivatives offer a promising avenue for exploring novel analgesics.
• Further research into these compounds could lead to new therapeutic strategies for pain relief.